Director PARSHALL B LYNNE sold IONIS PHARMACEUTICALS INC ($IONS) shares on the open market six times in the last year, totaling about $2 million, with the latest sale on February 11, 2026. These sales rank 3,499th among insiders by value. She also sold CYTOKINETICS INC ($CYTK) shares twice for $630,000, most recently on March 2, 2026, ranking 5,981st. Among nearly 12,000 insiders with sales averaging $8.6 million over six transactions, PARSHALL B LYNNE made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $61.21 | 17,933.0000 | 122,264,929 | 21.80% | 0.00% |
| Feb. 11, 2026 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $82.72 | 56,344.0000 | 158,964,772 | 8.15% | 0.00% |
| Nov. 19, 2025 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $64.73 | 22,933.0000 | 122,264,929 | 17.90% | 0.00% |
| Oct. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $71.74 | 61,344.0000 | 158,964,772 | 7.54% | 0.00% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 10750 | $50.42 | 75,594.0000 | 158,964,772 | 12.45% | 0.01% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 9250 | $51.49 | 66,344.0000 | 158,964,772 | 12.24% | 0.01% |
| Aug. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 4600 | $41.87 | 86,744.0000 | 158,964,772 | 5.04% | 0.00% |
| Aug. 6, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 400 | $42.63 | 86,344.0000 | 158,964,772 | 0.46% | 0.00% |
| July 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 4079 | $0.00 | 91,344.0000 | 158,964,772 | 4.67% | 0.00% |
| July 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Restricted Stock Unit | 4079 | $0.00 | 5,220.0000 | 158,964,772 | 43.86% | 0.00% |
| July 1, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Restricted Stock Unit | 5220 | $0.00 | 9,299.0000 | 158,964,772 | 127.97% | 0.00% |
| July 1, 2025 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (right to buy) | 11518 | $0.00 | 11,518.0000 | 158,964,772 | 9999.99% | 0.01% |
| June 17, 2025 | Foghorn Therapeutics Inc. | $FHTX | PARSHALL B LYNNE | Not found | A | Stock Option (right to buy) | 25000 | $4.79 | 25,000.0000 | 54,899,432 | 9999.99% | 0.05% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Common Stock | 7333 | $0.00 | 27,933.0000 | 118,410,689 | 35.60% | 0.01% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| Sept. 9, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| Sept. 9, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $54.92 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Sept. 9, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 26, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $57.26 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Aug. 26, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| Aug. 26, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Aug. 12, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 10,000.0000 | 0 | 33.33% | 0.00% |
| Aug. 12, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $55.20 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Aug. 12, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 29, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 29, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 0 | 25.00% | 0.00% |
| July 29, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $59.84 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Restricted Stock Unit | 4677 | $0.00 | 4,079.0000 | 0 | 53.41% | 0.00% |
| July 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 4677 | $0.00 | 87,265.0000 | 0 | 5.66% | 0.00% |
| July 15, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 15, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 15, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $55.82 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (right to buy) | 10111 | $0.00 | 10,111.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Restricted Stock Unit | 4079 | $0.00 | 8,756.0000 | 0 | 87.21% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $54.22 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| June 26, 2024 | Foghorn Therapeutics Inc. | $FHTX | PARSHALL B LYNNE | Not found | A | Stock Options (Right to buy) | 16000 | $5.52 | 16,000.0000 | 41,974,484 | 9999.99% | 0.04% |
| June 17, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| June 17, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 10,000.0000 | 0 | 33.33% | 0.00% |
| June 17, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $52.55 | 20,600.0000 | 0 | 19.53% | 0.00% |
| June 3, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $48.64 | 15,600.0000 | 0 | 24.27% | 0.00% |
| June 3, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 0 | 25.00% | 0.00% |
| June 3, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 20,600.0000 | 0 | 32.05% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Common Stock | 5600 | $0.00 | 20,600.0000 | 0 | 37.33% | 0.00% |
| Dec. 27, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 50000 | $47.34 | 132,588.0000 | 0 | 60.54% | 0.00% |
| Dec. 27, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 50000 | $50.23 | 82,588.0000 | 0 | 37.71% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 42525 | $47.34 | 125,113.0000 | 0 | 51.49% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 42525 | $50.19 | 82,588.0000 | 0 | 33.99% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (right to buy) | 25113 | $0.00 | 92,525.0000 | 0 | 21.35% | 0.00% |
| Dec. 27, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (right to buy) | 50000 | $0.00 | 42,525.0000 | 0 | 54.04% | 0.00% |
| Dec. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (right to buy) | 42525 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 25113 | $51.46 | 82,588.0000 | 0 | 23.32% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 25113 | $47.34 | 107,701.0000 | 0 | 30.41% | 0.00% |
| Sept. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | S | Common Stock | 10000 | $45.13 | 82,588.0000 | 0 | 10.80% | 0.00% |
| July 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Restricted Stock Unit | 1777 | $0.00 | 10,010.0000 | 0 | 15.08% | 0.00% |
| July 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Restricted Stock Unit | 5333 | $0.00 | 4,677.0000 | 0 | 53.28% | 0.00% |
| July 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 5333 | $0.00 | 92,588.0000 | 0 | 6.11% | 0.00% |
| July 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | M | Common Stock | 1777 | $0.00 | 87,255.0000 | 0 | 2.08% | 0.00% |
| July 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (right to buy) | 10321 | $0.00 | 10,321.0000 | 0 | 9999.99% | 0.00% |
| July 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | PARSHALL B LYNNE | Director | A | Restricted Stock Unit | 4677 | $0.00 | 11,787.0000 | 0 | 65.78% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Common Stock | 5000 | $0.00 | 15,000.0000 | 0 | 50.00% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |